Expands development of novel GBS vaccine in older adult population Targeting significant and growing unmet medical need of GBS infection COPENHAGEN, Denmark, April 17, 2023 /PRNewswire/ — MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group…